Why Am I Not Losing Weight on GLP-1? Common Reasons and What Your Clinician Can Adjust

A patient came in recently after doing a liveaboard trip out of Chalong. Two months on semaglutide, injections done correctly every week, appetite noticeably reduced, and yet the scale had barely shifted since week three. She was not doing anything obviously wrong. The drug was just not doing what she expected it to do yet.

This situation is common, whether in long-stay expats managing weight in Chalong and Rawai, or visitors who started GLP-1 therapy before flying to Phuket and expected to keep progressing through their trip. The frustration is real. But there is almost always a fixable reason, and it usually falls into one of three categories: a dose issue, a lifestyle issue, or an underlying condition no one has tested for yet.

Working out which one applies to you is what a clinical review is for. You can have that conversation at Takecare Clinic Phuket without booking ahead.

The First Few Weeks on GLP-1 Are Not a Fair Test

Semaglutide and tirzepatide are started at a low dose and increased gradually. This is deliberate: it reduces nausea and other side effects. But it also means you are not at a therapeutic dose for most of the first few months.

The medication also needs time to reach a stable level after each dose change. A meaningful plateau is one that persists for four to six weeks at a stable, therapeutic dose. Four weeks at a starting dose tells you very little. Note that GLP-1 medications should not be used in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and anyone who develops symptoms such as severe abdominal pain, vomiting, or signs of an allergic reaction while on these medications should see a doctor promptly.

The Hidden Diet Mistakes That Undercut GLP-1

Appetite suppression is real with these medications. The problem is that eating less does not always mean eating at a calorie deficit.

Alcohol is a common gap. A couple of drinks at a beach club in Surin or an evening in Patong adds calories that feel invisible because they do not register as food. Over a week, the gap between perceived and actual intake closes quickly.

Caloric compensation is the other pattern. Some people unconsciously reward reduced appetite at meals with higher-calorie snacks, or switch to smaller portions of very energy-dense food. GLP-1 suppresses appetite signals, not judgment about what you eat.

Why Losing Muscle Could Stall Your Scale

GLP-1 medications reduce overall calorie intake. Without adequate protein and resistance exercise, some of what you lose will be muscle rather than fat. Muscle is metabolically active. Losing it reduces your resting energy expenditure, which makes a calorie deficit harder to sustain.

This is a body composition problem, not a weight problem. Your scale may not move, but your body fat percentage could still be shifting. If muscle loss is significant, your metabolism slows and the same dose produces less effect than it did initially. Protein targets and structured exercise are not optional extras on a GLP-1 protocol. They are part of how the medication is supposed to work.

Underlying Conditions That Can Block GLP-1 Results

Two conditions are worth flagging specifically: hypothyroidism and polycystic ovary syndrome (PCOS). Both affect the metabolic pathways that GLP-1 medications rely on. Undiagnosed or undertreated hypothyroidism slows your metabolism independently of anything the drug does. PCOS involves insulin resistance that may require more than appetite suppression to address.

If you are an expat in Phuket who has not had a blood panel in the last year or two, this is worth checking. A basic workup, including thyroid-stimulating hormone, fasting glucose, and relevant hormonal markers, can be arranged the same day as a GLP-1 review. A same-day blood test in Phuket is straightforward to organise, and the results can change the clinical approach significantly.

Could Another Medication Be Working Against You?

Some medications promote weight gain or actively work against weight loss. Corticosteroids are the most significant: they raise cortisol, drive appetite, and shift fat distribution. Certain antidepressants and antipsychotics have similar effects. Some diabetes medications outside the GLP-1 class also carry weight gain as a side effect.

If you started a new medication around the same time your progress stalled, that timing is worth raising with a clinician. It does not mean stopping the other drug. It may mean adjusting your approach, or adjusting the GLP-1 dose to account for the counter-effect.

Is Your GLP-1 the Right Formulation and Dose?

This matters more than most people realise, particularly in Thailand. Compounded versions of semaglutide are widely available and significantly cheaper than branded products. They are not held to the same regulatory standards as Ozempic or Wegovy. Concentration, purity, and dose accuracy can vary between compounded batches.

A lower-than-expected dose in your pen means a lower-than-expected effect in your body. If you are using a compounded formulation and your progress has stalled, the formulation itself is a legitimate clinical variable. A prescriber can review what you are using and advise on whether switching to a regulated product is appropriate.

Are Some People Genuine GLP-1 Non-Responders?

A small subset of people do not respond well to GLP-1 medications regardless of dose, adherence, or lifestyle. Variants in the GLP-1 receptor gene (GLP1R) have been identified as a possible contributing factor in some studies, though routine genetic testing for GLP-1 response is not yet standard practice and this area remains under active investigation.

If you have been at an adequate therapeutic dose for several months, your technique and storage are correct, your diet and activity are well-managed, there is no interfering medication, and your blood panel is normal, then a genuine non-response is worth discussing with your clinician. That conversation shifts toward whether tirzepatide is appropriate if you are currently on semaglutide, or whether a different clinical approach makes sense. It is not a dead end.

What Your Clinician Can Actually Adjust

Dose titration is the most obvious lever. If you have not yet reached the higher end of your medication’s approved dose range and your side effect profile allows it, increasing the dose is a logical next step with clinical oversight.

Switching agents is another option. Tirzepatide acts on both GLP-1 and GIP receptors, and some patients who plateau on semaglutide respond better after switching. Adding structured dietary guidance, a resistance training plan, sleep assessment, or treatment for a concurrent condition often bridges the gap between a partial response and a meaningful one. None of these are things to self-prescribe. They require a review, and that review is what you should be asking for. You can find out what to ask your doctor when GLP-1 isn’t working before you come in, which makes the conversation shorter and more useful.

Getting a GLP-1 Review in Phuket Without an Appointment

Managing a GLP-1 protocol from Phuket is practical, whether you are here for six weeks or six years. You do not need a prior relationship with a clinic or a referral from home.

At Takecare Clinic Phuket, you can walk in for a same-day GLP-1 medication review, get a blood panel run if an underlying condition is suspected, and have a prescription refill arranged if you are running low mid-stay.

Bring your current medication, note what dose you are on and for how long, and flag any other medications you take. That is enough to start a useful review.